Date	Investors	Amount	Round
Oct 2011	F-Prime	$5m	SERIES A
Nov 2012	Eight Roads Ventures F-Prime Lilly Asia Ventures	$25m	SERIES B
Jan 2015	Eight Roads Ventures Temasek Legend Capital Hillhouse Capital F-Prime Lilly Asia Ventures Frontline BioVentures	$115m	SERIES C
Nov 2016	Temasek Legend Capital Hillhouse Capital Taikang Group State Development & Investment Corporation (SDIC) China Life Private Equity Investment	$260m	SERIES D
Apr 2018	Temasek Legend Capital Hillhouse Capital Rock Springs Capital Cormorant Asset Management Lilly Asia Ventures Taikang Group Ally Bridge Group Capital Group Private Markets	$150m Valuation: $1.0b	SERIES E
Oct 2018	N/A	$421m Valuation: $2.0b	IPO
Total Funding		€505m

China, Suzhou

Are you an employee or an investor of this company?

Innovent Biologics

Company information